323 related articles for article (PubMed ID: 21570676)
1. Methylphenidate and fluphenazine, but not amphetamine, differentially affect impulsive choice in spontaneously hypertensive, Wistar-Kyoto and Sprague-Dawley rats.
Wooters TE; Bardo MT
Brain Res; 2011 Jun; 1396():45-53. PubMed ID: 21570676
[TBL] [Abstract][Full Text] [Related]
2. Adolescent D-amphetamine treatment in a rodent model of ADHD: Pro-cognitive effects in adolescence without an impact on cocaine cue reactivity in adulthood.
Jordan CJ; Taylor DM; Dwoskin LP; Kantak KM
Behav Brain Res; 2016 Jan; 297():165-79. PubMed ID: 26467602
[TBL] [Abstract][Full Text] [Related]
3. Methylphenidate reduces impulsive behaviour in juvenile Wistar rats, but not in adult Wistar, SHR and WKY rats.
Bizot JC; Chenault N; Houzé B; Herpin A; David S; Pothion S; Trovero F
Psychopharmacology (Berl); 2007 Aug; 193(2):215-23. PubMed ID: 17406857
[TBL] [Abstract][Full Text] [Related]
4. Impulsive choice and environmental enrichment: effects of d-amphetamine and methylphenidate.
Perry JL; Stairs DJ; Bardo MT
Behav Brain Res; 2008 Nov; 193(1):48-54. PubMed ID: 18534693
[TBL] [Abstract][Full Text] [Related]
5. Differences between electrically-, ritalin- and D-amphetamine-stimulated release of [3H]dopamine from brain slices suggest impaired vesicular storage of dopamine in an animal model of Attention-Deficit Hyperactivity Disorder.
Russell V; de Villiers A; Sagvolden T; Lamm M; Taljaard J
Behav Brain Res; 1998 Jul; 94(1):163-71. PubMed ID: 9708847
[TBL] [Abstract][Full Text] [Related]
6. Methylphenidate does not increase ethanol consumption in a rat model for attention-deficit hyperactivity disorder-the spontaneously hypertensive rat.
Soeters HS; Howells FM; Russell VA
Metab Brain Dis; 2008 Sep; 23(3):303-14. PubMed ID: 18665438
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of d-amphetamine on impulsive choice in spontaneously hypertensive and Wistar-Kyoto rats.
Hand DJ; Fox AT; Reilly MP
Behav Pharmacol; 2009 Sep; 20(5-6):549-53. PubMed ID: 19654504
[TBL] [Abstract][Full Text] [Related]
8. Spontaneously hypertensive rats do not predict symptoms of attention-deficit hyperactivity disorder.
van den Bergh FS; Bloemarts E; Chan JS; Groenink L; Olivier B; Oosting RS
Pharmacol Biochem Behav; 2006 Mar; 83(3):380-90. PubMed ID: 16580713
[TBL] [Abstract][Full Text] [Related]
9. Strain differences in self-administration of methylphenidate and sucrose pellets in a rat model of attention-deficit hyperactivity disorder.
Marusich JA; McCuddy WT; Beckmann JS; Gipson CD; Bardo MT
Behav Pharmacol; 2011 Dec; 22(8):794-804. PubMed ID: 22015805
[TBL] [Abstract][Full Text] [Related]
10. Effects of methylphenidate on attentional set-shifting in a genetic model of attention-deficit/hyperactivity disorder.
Cao AH; Yu L; Wang YW; Wang JM; Yang LJ; Lei GF
Behav Brain Funct; 2012 Feb; 8(1):10. PubMed ID: 22369105
[TBL] [Abstract][Full Text] [Related]
11. Spontaneously hypertensive (SHR) rats choose more impulsively than Wistar-Kyoto (WKY) rats on a delay discounting task.
Aparicio CF; Hennigan PJ; Mulligan LJ; Alonso-Alvarez B
Behav Brain Res; 2019 May; 364():480-493. PubMed ID: 28963043
[TBL] [Abstract][Full Text] [Related]
12. Adolescent d-amphetamine treatment in a rodent model of attention deficit/hyperactivity disorder: impact on cocaine abuse vulnerability in adulthood.
Jordan CJ; Lemay C; Dwoskin LP; Kantak KM
Psychopharmacology (Berl); 2016 Dec; 233(23-24):3891-3903. PubMed ID: 27600990
[TBL] [Abstract][Full Text] [Related]
13. Methylphenidate normalizes elevated dopamine transporter densities in an animal model of the attention-deficit/hyperactivity disorder combined type, but not to the same extent in one of the attention-deficit/hyperactivity disorder inattentive type.
Roessner V; Sagvolden T; Dasbanerjee T; Middleton FA; Faraone SV; Walaas SI; Becker A; Rothenberger A; Bock N
Neuroscience; 2010 Jun; 167(4):1183-91. PubMed ID: 20211696
[TBL] [Abstract][Full Text] [Related]
14. Adolescent methylphenidate treatment differentially alters adult impulsivity and hyperactivity in the Spontaneously Hypertensive Rat model of ADHD.
Somkuwar SS; Kantak KM; Bardo MT; Dwoskin LP
Pharmacol Biochem Behav; 2016 Feb; 141():66-77. PubMed ID: 26657171
[TBL] [Abstract][Full Text] [Related]
15. Advancing the spontaneous hypertensive rat model of attention deficit/hyperactivity disorder.
Kantak KM; Singh T; Kerstetter KA; Dembro KA; Mutebi MM; Harvey RC; Deschepper CF; Dwoskin LP
Behav Neurosci; 2008 Apr; 122(2):340-57. PubMed ID: 18410173
[TBL] [Abstract][Full Text] [Related]
16. Baseline behavior, but not sensitivity to stimulant drugs, differs among spontaneously hypertensive, Wistar-Kyoto, and Sprague-Dawley rat strains.
Ferguson SA; Paule MG; Cada A; Fogle CM; Gray EP; Berry KJ
Neurotoxicol Teratol; 2007; 29(5):547-61. PubMed ID: 17689921
[TBL] [Abstract][Full Text] [Related]
17. Increased glutamate-stimulated release of dopamine in substantia nigra of a rat model for attention-deficit/hyperactivity disorder--lack of effect of methylphenidate.
Warton FL; Howells FM; Russell VA
Metab Brain Dis; 2009 Dec; 24(4):599-613. PubMed ID: 19821016
[TBL] [Abstract][Full Text] [Related]
18. Impulsive choice behavior in four strains of rats: evaluation of possible models of Attention-Deficit/Hyperactivity Disorder.
Garcia A; Kirkpatrick K
Behav Brain Res; 2013 Feb; 238():10-22. PubMed ID: 23085479
[TBL] [Abstract][Full Text] [Related]
19. Methylphenidate and Atomoxetine-Responsive Prefrontal Cortical Genetic Overlaps in "Impulsive" SHR/NCrl and Wistar Rats.
Dela Peña I; Dela Peña IJ; de la Peña JB; Kim HJ; Shin CY; Han DH; Kim BN; Ryu JH; Cheong JH
Behav Genet; 2017 Sep; 47(5):564-580. PubMed ID: 28744604
[TBL] [Abstract][Full Text] [Related]
20. Methylphenidate affects striatal dopamine differently in an animal model for attention-deficit/hyperactivity disorder--the spontaneously hypertensive rat.
Russell VA; de Villiers AS; Sagvolden T; Lamm MC; Taljaard JJ
Brain Res Bull; 2000 Sep; 53(2):187-92. PubMed ID: 11044595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]